Welcome to our dedicated page for Marex Group SEC filings (Ticker: MRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles U.S. Securities and Exchange Commission filings for Marex Group plc (NASDAQ: MRX), a diversified global financial services platform operating across energy, commodities and financial markets. As a foreign private issuer, Marex files an annual report on Form 20-F and periodic Form 6-K reports that furnish press releases and financial information to U.S. investors.
Recent Form 6-K filings include earnings-related disclosures, such as interim results, third quarter results and preliminary trading updates. These documents provide detail on revenue, adjusted profit before tax, segment performance across Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions, as well as information on net commission income, net trading income, net interest income and net physical commodities income. They also discuss non-IFRS measures, their definitions and reconciliations to the most comparable IFRS metrics.
Other 6-Ks relate to corporate actions and governance, including press releases about purchases of ordinary shares by the Chief Executive Officer and other directors and officers. These filings help investors track insider share dealings and understand how management and board members are building or adjusting their holdings in Marex.
Filings may also reference capital and ratings developments, such as senior debt issuances, Additional Tier 1 instruments and credit ratings from S&P Global Ratings for Marex Group and its U.S. subsidiary, Marex Capital Markets Inc. Together, these disclosures provide insight into the Group’s capital structure, funding and external credit assessment.
On Stock Titan, Marex’s SEC filings are updated as new documents are released on EDGAR. AI-powered tools can assist users by surfacing key points from lengthy filings, highlighting segment trends, explaining non-IFRS measures and drawing attention to notable items such as insider transactions and earnings commentary, helping readers navigate the technical language common in cross-border capital markets reporting.
Marex Group Limited is offering Autocallable Leveraged Barrier Notes linked to the worst performing of the S&P 500 Index and the Nasdaq-100 Index due August 2, 2029. The Notes have a Principal Amount of $1,000 per Note, an Upside Participation Rate of 150% and a Barrier Percentage of -30%. The Notes may be automatically called if each Underlying equals or exceeds its Call Threshold on the Call Observation Date, yielding the Principal Amount plus a Call Premium; otherwise payment at maturity depends on the Reference Return of the Worst Performing Underlying. Trade Date and Pricing Date are July 30, 2026; Original Issue Date is August 4, 2026.
Marex Group Limited is offering Issuer Callable Contingent Income Barrier Notes linked to the worst performing of the S&P 500, Russell 2000 and Nasdaq-100. Each Note has a $1,000 Principal Amount, an estimated initial value of $950.00–$990.00 per Note and a Contingent Coupon of at least $30.00 per quarter (3.00% per quarter; 12.00% per annum). The Trade and Pricing Date are July 30, 2026, Original Issue Date is August 4, 2026, Final Valuation Date is July 30, 2029 and Maturity Date is August 2, 2029. Coupons are payable only if each underlying closes at or above its Coupon Trigger (70% of initial value) on a Coupon Determination Date. At maturity, if the Worst Performing Underlying’s Reference Return is >= -30.00%, holders receive principal plus final Contingent Coupon; if < -30.00% they receive a loss equal to the Reference Return applied to principal, potentially losing up to 100% of principal. The issuer may redeem the Notes on quarterly Call Payment Dates. The Notes are senior unsecured obligations of Marex and subject to Marex credit risk, limited liquidity, pricing that reflects hedging and distribution costs, and uncertain U.S. tax treatment.
Marex Group Limited is offering Capped Leveraged Buffered Notes linked to the S&P 500® Index due August 3, 2028. Each Note has a $1,000 Principal Amount and a Final Valuation Date of July 31, 2028. The Notes provide an Upside Participation Rate of 150% (1.50x) subject to a Maximum Return of 24.00%, and include a Buffer Percentage of -10.00% (Buffer Amount 10.00%). If the Reference Return is below the Buffer Percentage, loss is 1% of principal for each 1% index decline beyond 10%, up to a potential loss of 90% of principal. The Estimated Initial Value on the Trade Date is expected to be between $950.00 and $990.00 per Note, which the document states will be less than the price to public. Marex has applied to list the Notes on the Vienna MTF. The Notes are senior unsecured obligations of Marex and are subject to Marex credit risk and other risks discussed in the "Risk Factors" sections.
Marex Group Limited is offering Contingent Income (with Memory) Barrier Notes linked to the worst performing common stock of GE Vernova Inc., General Motors Company and Intuitive Surgical, Inc.. The Notes have a $1,000 principal amount per note, a Pricing Date of July 28, 2026, a Trade Date of July 29, 2026, an Original Issue Date of July 31, 2026 and a scheduled Maturity Date of August 2, 2029.
The Notes pay a monthly contingent coupon (with memory) if each underlying’s Closing Price on a Coupon Determination Date is at or above its Coupon Trigger (50.00% of Initial Value). The stated monthly coupon equals at least $15.67 per $1,000 (1.567% monthly, equivalent to 18.804% per annum), to be fixed on the Trade Date. At maturity the holder receives $1,000 plus the final contingent coupon if the Worst Performing Underlying’s Reference Return is greater than or equal to -50.00%; otherwise the maturity payment equals $1,000 plus ($1,000 × Reference Return), exposing holders to up to 100% principal loss if the Final Value is below the Barrier Value (50.00% of Initial Value).
Marex Group Limited filed an amended Form 6-K to add Exhibit 99.6, its Bermuda Memorandum of Association and related share capital documentation. The Bermuda Registrar of Companies certified that a Memorandum of Increase of Share Capital for Marex was delivered on July 1, 2026 under the Companies Act 1981. The filing records that the company is an exempted company limited by shares with unrestricted objects and powers, including the ability to issue redeemable preference shares and hold treasury shares. It also shows the USD authorised share capital changing from 0.003102 to 151,159.825641, reflecting an increase of 151,159.822539 in authorised capital.
Marex Group Limited is offering Autocallable Contingent Income Barrier Notes linked to the MerQube US Large‑Cap Vol Advantage Index due July 31, 2031. The Notes pay a quarterly Contingent Coupon of $39.25 per $1,000 (3.925% per quarter; 15.70% per annum) only if the Reference Asset meets the Coupon Trigger on each determination date, and may be automatically called if the Reference Asset closes at or above its Call Threshold (100% of Initial Value) on any Call Observation Date. If the Notes are not called, payment at maturity depends on the Reference Return: holders receive $1,000 plus the final Contingent Coupon when the Reference Return is greater than or equal to -40.00%, but will suffer a dollar‑for‑dollar loss below that level (up to 100% loss of principal). The Notes reflect Marex’s credit risk, include a daily 6.0% per annum decrement in the Reference Asset calculation and reference a volatility‑targeting strategy (35% target) that can employ up to 500% exposure; investors should review the Risk Factors and tax discussion in the prospectus materials.
Marex Group Limited has completed a corporate reorganization that makes a new Bermuda company the parent of the Marex group. On July 1, 2026, holders of ordinary shares in the former parent, Marex Group plc, received ordinary shares in Marex Group Limited on a one-for-one basis, and the former parent became a wholly owned subsidiary.
The former parent has been renamed Marex UK Holdings Limited and converted into a private limited company in England and Wales. Following this redomiciliation, Marex Group Limited filed post-effective amendments to existing shelf registration statements and, on July 6, 2026, entered into multiple supplemental indentures so it now directly assumes all obligations under the group’s senior notes, structured notes, subordinated notes and contingent capital convertible securities.
Marex Group Limited is registering senior unsecured Notes linked to one or more Reference Assets, which may include exchange-traded funds or trusts (each, a “Fund”), baskets of Funds, commodities or other measures. The supplement describes additional terms, Fund-specific risks, hedging practices and example Funds that may underlie the Notes.
The Notes will be direct, senior, unsecured obligations of Marex, not bank deposits or government-insured. Marex expects to hedge obligations and may use affiliates as counterparties. Pricing supplements or free writing prospectuses will specify the applicable Reference Asset, exact terms, and any additional risk factors.
Marex Group Limited may offer and sell senior unsecured debt obligations (the "Notes") linked to a specified "Reference Asset" (for example, equity indices, baskets or the worst performing of multiple indices) from time to time. The underlying supplement describes additional terms, index descriptions and risks and states that each offering will be governed by an applicable free writing prospectus or pricing supplement together with the Prospectus Supplement and Base Prospectus. The Notes will be direct, senior, unsecured obligations of Marex and will rank equally with other senior unsecured indebtedness; they will not be bank deposits or government‑insured. Prospective purchasers should review the Risk Factors and the Use of Proceeds and Hedging descriptions in the Prospectus Supplement.
Marex Group Limited filed a supplement describing the terms for senior unsecured Notes linked to a Reference Asset, including single equity securities, ADRs or baskets that may include equities. The supplement (dated July 6, 2026) explains valuation dates, Market Disruption Events, anti‑dilution adjustments, physical delivery mechanics and the calculation agent’s broad discretionary powers. The Notes are unsecured obligations, expected to be admitted to trading on the Vienna MTF, and are not FDIC‑insured or government guaranteed.